HLS Therapeutics Announces NILEMDOTM (bempedoic acid) is now available in Canada for the Reduction of LDL-Cholesterol in Patients at Risk of Cardiovascular Disease
CareRx Reports 2025 Year-End and Fourth Quarter Results
Aurora Spine cuts loan rate, extends insider note
AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER
Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call
Safe Supply testing Nirlab Nirlight devices in field
Sernova arranges $7.1-million in financings
Safe Supply Confirms NIRLAB Drug Analysis Devices Actively Deployed and Under Field Evaluation by Government Stakeholders
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
DRI Healthcare Reports Fourth Quarter and Annual 2025 Results
Perimeter receives FDA premarket approval for Claire
Quipt Home holders OK acquisition by Kingswood, Forager
Pharmather to expand PharmaPatch platform